nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
|
Masotti, Alessandro |
|
2002 |
36 |
1 |
p. 99-103 5 p. |
artikel |
2 |
AH6809 antagonizes non-small cell lung cancer prostaglandin receptors
|
Casibang, Marchessini |
|
2002 |
36 |
1 |
p. 33-42 10 p. |
artikel |
3 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer
|
Atagi, Shinji |
|
2002 |
36 |
1 |
p. 105-111 7 p. |
artikel |
4 |
Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer
|
Tanaka, Fumihiro |
|
2002 |
36 |
1 |
p. 27-32 6 p. |
artikel |
5 |
A prospective study of a total material of lung cancer from a county in Sweden 1997–1999: gender, symptoms, type, stage, and smoking habits
|
Koyi, Hirsh |
|
2002 |
36 |
1 |
p. 9-14 6 p. |
artikel |
6 |
A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer
|
Wu, Yi-long |
|
2002 |
36 |
1 |
p. 1-6 6 p. |
artikel |
7 |
Calendar of Events
|
|
|
2002 |
36 |
1 |
p. vii- 1 p. |
artikel |
8 |
CEA and CA 549 in serum and pleural fluid of patients with pleural effusion
|
Hernández, Luis |
|
2002 |
36 |
1 |
p. 83-89 7 p. |
artikel |
9 |
Complete mediastinal lymph node dissection—does it make a difference?
|
Keller, Steven M |
|
2002 |
36 |
1 |
p. 7-8 2 p. |
artikel |
10 |
Contents
|
|
|
2002 |
36 |
1 |
p. v- 1 p. |
artikel |
11 |
Contents continued
|
|
|
2002 |
36 |
1 |
p. vi- 1 p. |
artikel |
12 |
Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer
|
Sasaki, Hidefumi |
|
2002 |
36 |
1 |
p. 71-76 6 p. |
artikel |
13 |
Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis
|
Mager, Hans-Jurgen |
|
2002 |
36 |
1 |
p. 77-81 5 p. |
artikel |
14 |
Influence of delays on survival in the surgical treatment of bronchogenic carcinoma
|
Aragoneses, Federico G. |
|
2002 |
36 |
1 |
p. 59-63 5 p. |
artikel |
15 |
Instructions to authors
|
|
|
2002 |
36 |
1 |
p. 113-114 2 p. |
artikel |
16 |
Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer
|
Veronesi, G. |
|
2002 |
36 |
1 |
p. 91-97 7 p. |
artikel |
17 |
Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer
|
Park, Jae Yong |
|
2002 |
36 |
1 |
p. 15-16 2 p. |
artikel |
18 |
Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer
|
Ortegel, John W |
|
2002 |
36 |
1 |
p. 17-25 9 p. |
artikel |
19 |
Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan
|
Motohiro, Akira |
|
2002 |
36 |
1 |
p. 65-69 5 p. |
artikel |
20 |
Radiologic–prognostic correlation in patients with small pulmonary adenocarcinomas
|
Kondo, Tetsuro |
|
2002 |
36 |
1 |
p. 49-57 9 p. |
artikel |
21 |
Survival and risk model for stage IB non-small cell lung cancer
|
Padilla, J |
|
2002 |
36 |
1 |
p. 43-48 6 p. |
artikel |